News
US PHARMACEUTICAL giant Merck has axed plans to launch a £1bn (US$1.35bn) research & development (R&D) centre in London.
EUROPEAN pharmaceutical giant Novo Nordisk plans to cut over 10% of its global workforce, as competition intensifies in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback